Search Results for: ACT 1 test

Testing for Cervical Cancer: CINtec® PLUS Cytology

doctor and patient

Cervical cancer is one of the most preventable forms of cancer. However, each year in the United States, an estimated 13,000 new cases of cervical cancer are diagnosed and 4,000 women die of this cancer, according to the Centers for Disease Control and Prevention. Screening tests and the HPV vaccine are the keys to prevention. When cervical cancer […]

RSV, Flu, & COVID-19: Get tested for early diagnosis and treatment

It’s not just flu season. It’s the flu, COVID-19, and RSV (respiratory syncytial virus) season. While the flu has been diminished for the past two years due to the COVID-19 pandemic safety measures, such as people staying home and wide-spread masking, experts suggest that this could lead to reduced population immunity.1 These factors can bring […]

Aspira Women’s Health, BioReference to distribute blood tests to detect the risk of ovarian malignancy

LabPulse.com Aspira Women’s Health on Wednesday announced a collaboration for ovarian cancer testing with Opko Health’s BioReference Laboratories. The firms will co-market and distribute Aspira’s Ova1Plus, which combines its U.S. Food and Drug Administration-cleared blood tests, Ova1 and Overa, to detect the risk of ovarian malignancy in women with adnexal masses prior to surgery. Under the […]

Heading Back to College? Study-Up on STI Prevention & Testing

If you’re packing up to head back to campus or are sending off a scholar – the start of a new semester is the perfect time to encourage sexual health education. Staying informed about the heightened risk for sexually transmitted infections that college students may face is an important factor in supporting sexual and overall […]

5 Things to Know About Testicular Cancer

In 2022, it’s estimated that 9,910 new cases of testicular cancer will be diagnosed in the United States, according to the American Cancer Society.1 This April, for Testicular Cancer Awareness Month, we’re highlighting some key information to help raise awareness and encourage education – read on for five important things to know about testicular cancer. […]

Penguins’ COVID-19 Tester Has Become Part of the Family

NHL.com Nurse Guyanna Runion Ackison has done an outstanding job taking care of the team behind the scenes At the end of last season, Guyanna Runion Ackison, a nurse who handles the team’s COVID-19 testing through BioReference Laboratories, got a text from Penguins VP of communications Jen Bullano Ridgley saying that Sidney Crosby had left her something […]

Valentine’s Day Ideas during COVID-19

February brings the season of love, but welcoming another Valentine’s Day amid the COVID-19 pandemic may still have its challenges. Consider some COVID-19-friendly ways to help celebrate Valentine’s Day 2022 safely. Valentine’s Day Ideas during COVID-19 As we continue to navigate the persistent Omicron variant, coming up with Valentine’s Day ideas might still take some […]

What Holiday Activities are Safe during the COVID-19 Pandemic?

Each year, the holiday season brings opportunities for festive fun. However, with the emergence of the Omicron variant amid the continuing COVID-19 pandemic, planning for safe holiday activities could still be a challenge. Though reducing your risk of exposure to COVID-19 to zero may be difficult – here, we offer a few creative holiday activities, […]

COVID-19 – Connecting with Friends & Family during the Holidays

Festive celebrations are an important part of the winter holiday season. From parties to feasts to opening presents, many cherished holiday traditions have one thing in common – gathering with friends and family. Taking precautions to help keep loved ones safe from COVID-19 should be an important part of your plan this year, especially with […]

OPKO Health Receives U.S. FDA Approval for the 4Kscore® Test

MIAMI, Dec. 08, 2021 (GLOBE NEWSWIRE) — OPKO Health, Inc. (NASDAQ: OPK) today announced that the U.S. Food and Drug Administration (FDA) has approved OPKO’s 4Kscore Test. This test is approved for use in men age 45 and older who have not had a prior prostate biopsy or are biopsy negative and have an age-specific abnormal total PSA and/or […]